Loading...
Third-line chemotherapy in small-cell lung cancer: an international analysis.
Simos, D Sajjady, G Sergi, M Liew, M Califano, Raffaele Ho, C Leighl, N White, S Summers, Yvonne J Petrcich, W
Simos, D
Sajjady, G
Sergi, M
Liew, M
Califano, Raffaele
Ho, C
Leighl, N
White, S
Summers, Yvonne J
Petrcich, W
Citations
Altmetric:
Abstract
Small-cell lung cancer is an aggressive disease for which the mainstay of treatment is chemotherapy. Despite good initial responses most patients will relapse. Some will receive second-line therapy with clinical benefit, but for third-line chemotherapy there is little evidence to guide treatment decisions and the benefits of treatment are unknown. This study investigated the treatment of SCLC in the third-line setting.
Affiliation
Description
Date
2013-11-14
Publisher
Collections
Keywords
Type
Article
Citation
Third-line chemotherapy in small-cell lung cancer: an international analysis. 2013: Clin Lung Cancer